HDAC9 and cancer: Recently, histone deacetylase (HDAC) inhibitors receive lot of researchers’ attention because of its anticancer and antifibrotic potentials in experimental models of cancers and in recent years the applicability of HDAC inhibitors for the treatment of fibrotic disorders has been explored [40].